| There's been a bubbling up of commentary over the past year or so about how the psychedelic stocks might be the "next pot stocks" and enjoy some big market moves, and that's the pitch from Chris Wood over at RiskHedge, who's selling his newsletter by teasing us about his recent pick, a $2 stock that he says is the "#1 Play of the Psychedelic Medicine Revolution." So what is it? Thinkolator results are just a click away... |
